Open AccessIncidence of COVID-19 after vaccination. Analysis of publicly available data
Author(s) -
V. A. Divocha,
Walery Żukow,
А. І. Гоженко
Publication year - 2021
Publication title -
journal of education, health and sport
Language(s) - English
Resource type - Journals
ISSN - 2391-8306
DOI - 10.12775/jehs.2021.11.07.012
Subject(s) - medicine , incidence (geometry) , covid-19 , vaccination , pandemic , coronavirus , myocarditis , virology , pediatrics , demography , outbreak , disease , infectious disease (medical specialty) , physics , optics , sociology
The coronavirus began in late 2019 in China's Hubei province. Since then, it has spread around the world. In the world, according to official data, more than 100 million people have become infected, more than 3 million have died from the coronavirus.On 18.03.2020, the first coronavirus vaccine trials began. Currently, 5 vaccines are used for vaccination: Pfizer, Moderna, AstraZeneca, Johnson and Johnson and Sputnik-V. No vaccine against COVID-19 protects a person 100% from the incidence of coronavirus. Average mortality rate as of 19.04.2021. 1. Pfizer-39,4; 2. Moderna-20,2; 3. AstraZeneca-12,8; 4. Johnson and Johnson-7,5; 5. Sputnik V-2,0. Pfizer and Moderna vaccines cause a risk of cardiovascular disease (myocarditis and pericarditis), thrombosis, bleeding and embolism.